QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
Log in

OTCMKTS:HYPMYHYPERA S A/S Stock Price, Forecast & News

$6.13
-0.13 (-2.12 %)
(As of 08/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.12
Now: $6.13
$6.35
50-Day Range
$5.87
MA: $6.37
$7.31
52-Week Range
$4.51
Now: $6.13
$9.53
Volume609,470 shs
Average Volume60,142 shs
Market Capitalization$3.87 billion
P/E Ratio14.25
Dividend Yield2.24%
Beta1.18
Hypera S.A. operates as a pharmaceutical company in Brazil. The company offers prescription medications under the Farmasa, Neo Química, and Luper brands; and over-the-counter medications comprising laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant, and other drugs under Gelol, Anapyon, Biotônico Fontoura, Epocler, Merthiolate, Tamarine, and Rinosoro brands. It also provides similars and generics under the Neo Química brand; dermocosmetics under the Lanidrant, Agecare, Dersab, Epidac, Epidrat, Episol, Hidramamy, Creme rejuvenecedor, Blancy, and Pielus brands; and food supplements and sweeteners. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. The company was founded in 2001 and is headquartered in São Paulo, Brazil.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.94 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:HYPMY
CUSIPN/A
CIKN/A
Phone55-11-3627-4206

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$834.89 million
Cash Flow$0.51 per share
Book Value$3.49 per share

Profitability

Net Income$294.97 million

Miscellaneous

Employees7,515
Market Cap$3.87 billion
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable
$6.13
-0.13 (-2.12 %)
(As of 08/10/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HYPMY News and Ratings via Email

Sign-up to receive the latest news and ratings for HYPMY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











HYPERA S A/S (OTCMKTS:HYPMY) Frequently Asked Questions

How has HYPERA S A/S's stock been impacted by COVID-19 (Coronavirus)?

HYPERA S A/S's stock was trading at $6.98 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HYPMY stock has decreased by 12.2% and is now trading at $6.1262.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of HYPERA S A/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HYPERA S A/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for HYPERA S A/S
.

When is HYPERA S A/S's next earnings date?

HYPERA S A/S is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for HYPERA S A/S
.

How often does HYPERA S A/S pay dividends? What is the dividend yield for HYPERA S A/S?

HYPERA S A/S announced a quarterly dividend on Monday, September 30th. Shareholders of record on Thursday, October 10th will be given a dividend of $0.04 per share on Friday, February 7th. This represents a $0.16 dividend on an annualized basis and a yield of 2.61%. The ex-dividend date of this dividend is Wednesday, October 9th.
View HYPERA S A/S's dividend history
.

Has HYPERA S A/S been receiving favorable news coverage?

News coverage about HYPMY stock has trended somewhat negative this week, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. HYPERA S A/S earned a media sentiment score of -1.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future.
View the latest news about HYPERA S A/S
.

Are investors shorting HYPERA S A/S?

HYPERA S A/S saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 900 shares, an increase of 800.0% from the December 15th total of 100 shares. Based on an average daily volume of 24,900 shares, the short-interest ratio is currently 0.0 days.
View HYPERA S A/S's Short Interest
.

Who are some of HYPERA S A/S's key competitors?

Who are HYPERA S A/S's key executives?

HYPERA S A/S's management team includes the following people:
  • Mr. Breno Toledo Pires de Oliveira, Chief Exec. Officer
  • Ms. Vivian Angiolucci, Chief Financial Officer
  • Mr. Carlos Roberto Scorsi, Chief Operating officer (Age 57)
  • Juliana Aguinaga Damião Salem, Chief Legal & Compliance Officer
  • Mr. Nelson José de Mello, Chief Corp. Relations Officer (Age 60)

What is HYPERA S A/S's stock symbol?

HYPERA S A/S trades on the OTCMKTS under the ticker symbol "HYPMY."

How do I buy shares of HYPERA S A/S?

Shares of HYPMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is HYPERA S A/S's stock price today?

One share of HYPMY stock can currently be purchased for approximately $6.13.

How big of a company is HYPERA S A/S?

HYPERA S A/S has a market capitalization of $3.87 billion and generates $834.89 million in revenue each year. HYPERA S A/S employs 7,515 workers across the globe.

What is HYPERA S A/S's official website?

The official website for HYPERA S A/S is www.hyperapharma.com.br.

How can I contact HYPERA S A/S?

HYPERA S A/S's mailing address is AV. MAGALHAES DE CASTRO 4800 - 24¿ ANDAR EDIFICIO CONTINENTAL TOWER, SAO PAULO D5, 05676-120. The company can be reached via phone at 55-11-3627-4206 or via email at [email protected]

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.